1612P Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy

Detalles Bibliográficos
Autores principales: Guven, D.C.C., Gulbahce Incesu, F.G., Yildirim, H.C., Erul, E., Chalabiyev, E., Aktas, B.Y., Yuce, D., Arik, Z., Kilickap, S., Aksoy, S., Erman, M., Hayran, K.M., Unal, S., Alp, A., Dizdar, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472463/
http://dx.doi.org/10.1016/j.annonc.2022.07.1705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472463/
http://dx.doi.org/10.1016/j.annonc.2022.07.1705

Ejemplares similares